Raymond James Financial Services Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 14,570 shares of IONS stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,570
Previous 15,335 4.99%
Holding current value
$1.02 Million
Previous $730,000 20.14%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
SELL
$40.06 - $51.86 $30,645 - $39,672
-765 Reduced 4.99%
14,570 $583,000
Q2 2024

Jul 19, 2024
BUY
$36.45 - $47.7 $66,594 - $87,147
1,827 Added 13.53%
15,335 $730,000
Q1 2024

Apr 22, 2024
SELL
$42.03 - $53.55 $5,842 - $7,443
-139 Reduced 1.02%
13,508 $585,000
Q4 2023

Jan 16, 2024
BUY
$43.39 - $51.63 $60,312 - $71,765
1,390 Added 11.34%
13,647 $690,000
Q3 2023

Oct 24, 2023
SELL
$38.5 - $47.13 $72,572 - $88,840
-1,885 Reduced 13.33%
12,257 $555,000
Q2 2023

Jul 25, 2023
SELL
$34.73 - $43.33 $399,742 - $498,728
-11,510 Reduced 44.87%
14,142 $580,000
Q1 2023

Apr 14, 2023
SELL
$33.58 - $41.2 $36,031 - $44,207
-1,073 Reduced 4.01%
25,652 $916,000
Q4 2022

Feb 08, 2023
SELL
$37.12 - $46.52 $216,743 - $271,630
-5,839 Reduced 17.93%
26,725 $1.01 Million
Q3 2022

Oct 25, 2022
SELL
$36.54 - $48.66 $791,675 - $1.05 Million
-21,666 Reduced 39.95%
32,564 $1.44 Million
Q2 2022

Aug 12, 2022
BUY
$31.71 - $43.0 $115,582 - $156,735
3,645 Added 7.21%
54,230 $2.01 Million
Q1 2022

May 11, 2022
BUY
$29.88 - $37.04 $47,927 - $59,412
1,604 Added 3.27%
50,585 $1.87 Million
Q4 2021

Feb 08, 2022
BUY
$25.61 - $35.1 $72,348 - $99,157
2,825 Added 6.12%
48,981 $1.49 Million
Q3 2021

Nov 02, 2021
BUY
$33.54 - $40.55 $44,440 - $53,728
1,325 Added 2.96%
46,156 $1.55 Million
Q2 2021

Aug 11, 2021
BUY
$34.54 - $47.25 $321,291 - $439,519
9,302 Added 26.18%
44,831 $1.79 Million
Q1 2021

May 14, 2021
BUY
$42.51 - $63.78 $729,769 - $1.09 Million
17,167 Added 93.49%
35,529 $1.6 Million
Q4 2020

Feb 12, 2021
BUY
$45.3 - $60.27 $166,296 - $221,251
3,671 Added 24.99%
18,362 $1.04 Million
Q3 2020

Nov 04, 2020
SELL
$47.45 - $62.95 $87,260 - $115,765
-1,839 Reduced 11.13%
14,691 $697,000
Q2 2020

Jul 17, 2020
BUY
$46.85 - $61.05 $20,660 - $26,923
441 Added 2.74%
16,530 $975,000
Q1 2020

Apr 21, 2020
BUY
$41.6 - $63.4 $114,566 - $174,603
2,754 Added 20.65%
16,089 $761,000
Q4 2019

Feb 12, 2020
SELL
$53.85 - $65.27 $196,929 - $238,692
-3,657 Reduced 21.52%
13,335 $806,000
Q3 2019

Nov 07, 2019
SELL
$59.06 - $72.15 $182,377 - $222,799
-3,088 Reduced 15.38%
16,992 $1.02 Million
Q2 2019

Aug 06, 2019
BUY
$62.09 - $86.14 $181,489 - $251,787
2,923 Added 17.04%
20,080 $1.29 Million
Q1 2019

May 06, 2019
BUY
$52.92 - $81.17 $393,354 - $603,336
7,433 Added 76.44%
17,157 $1.39 Million
Q4 2018

Feb 11, 2019
SELL
$43.37 - $59.54 $37,775 - $51,859
-871 Reduced 8.22%
9,724 $526,000
Q3 2018

Nov 14, 2018
BUY
$42.88 - $53.7 $5,231 - $6,551
122 Added 1.16%
10,595 $546,000
Q2 2018

Jul 30, 2018
SELL
$40.53 - $50.7 $331,373 - $414,523
-8,176 Reduced 43.84%
10,473 $436,000
Q1 2018

Apr 16, 2018
BUY
$44.08 - $55.05 $49,854 - $62,261
1,131 Added 6.46%
18,649 $822,000
Q4 2017

Feb 09, 2018
SELL
$50.3 - $64.39 $153,264 - $196,196
-3,047 Reduced 14.82%
17,518 $881,000
Q3 2017

Oct 26, 2017
SELL
$45.56 - $59.57 $41,459 - $54,208
-910 Reduced 4.24%
20,565 $1.04 Million
Q2 2017

Aug 15, 2017
BUY
N/A
21,475
21,475 $1.09 Million

Others Institutions Holding IONS

# of Institutions
414
Shares Held
149M
Call Options Held
1.72M
Put Options Held
722K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $9.93B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email